USPTO trademark

KAMVIDRA

RegisteredUSPTOWord markClass 5

"KAMVIDRA" is a word mark owned by AstraZeneca AB, filed at the USPTO on January 9, 2024. It is registered and covers class 5 (Pharmaceuticals).

View AstraZeneca AB portfolioGet this data via the API
Official USPTO record
KAMVIDRA trademark as filed
As filed with the USPTO
Status
Registered
Since December 9, 2025
Filed
January 9, 2024
Registered
December 9, 2025
Priority date
October 27, 2023
Claimed from European Union
Application no.
98348198
Registration no.
8055376
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns KAMVIDRA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca AB

Sodertalje, Sweden

6,107 trademarks in the portfolioView company

Representative

Cara M. Kearney

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services KAMVIDRA is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. 1(b) basis deleted; proceed to registration
  4. Case assigned to intent to use paralegal
  5. Notice of allowance cancelled
  6. Teas delete 1(b) basis received
  7. Noa e-mailed - sou required from applicant
  8. Official gazette publication confirmation e-mailed
  9. Published for opposition
  10. Notification of notice of publication e-mailed

10 earlier steps on the official record.

FAQ

About KAMVIDRA

Who owns the trademark "KAMVIDRA"?

The USPTO trademark "KAMVIDRA" (application 98348198) is owned by AstraZeneca AB.

What is the status of "KAMVIDRA"?

Its status at the USPTO is: registered.

When was "KAMVIDRA" registered?

It was registered on December 9, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KAMVIDRA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c7b-65af-7189-9584-18fe69ee2975
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c7b-65af-7189-9584-18fe69ee2975",
  "object": "trademark",
  "mark_text": "KAMVIDRA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98348198",
  "filing_date": "2024-01-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca AB",
      "entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
    }
  ]
}